Nishimura et al., 2015
- Systems pharmacology of adiposity reveals inhibition of EP300 as a common therapeutic mechanism of caloric restriction and resveratrol for obesity.
Frontiers in pharmacology
6:199
Full text @ Front Pharmacol
Marker Type | Symbol | Name |
---|---|---|
Gene | cd151l | CD151 antigen, like |
Gene | cel.2 | carboxyl ester lipase, tandem duplicate 2 |
Gene | cp | ceruloplasmin |
Gene | ednrba | endothelin receptor Ba |
Gene | f5 | coagulation factor V |
Gene | fads2 | fatty acid desaturase 2 |
Gene | fgb | fibrinogen beta chain |
Gene | gpx1a | glutathione peroxidase 1a |
Gene | igfbp1a | insulin-like growth factor binding protein 1a |
Gene | mitfa | melanocyte inducing transcription factor a |
Gene | rbp4 | retinol binding protein 4, plasma |
Gene | serpina1l | serine (or cysteine) proteinase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1, like |
Gene | tfa | transferrin-a |
Gene | tgfbi | transforming growth factor, beta-induced |
Gene | ucp1 | uncoupling protein 1 |
Gene | zar1 | zygote arrest 1 |